Apixaban F.C. Tabs 2.5mg/tab & 5mg/tab (under development)

Apixaban F.C. Tabs 2.5mg/tab & 5mg/tab (under development)
Product Description

Apixaban Film Coated Tablets 2.5mg & 5mg
Reference Product: Eliquis® / Bristol-Myers Squibb/Pfizer
Description: Prevention of stroke and systemic embolism in adult patients with non-valvular atrial fibrillation (NVAF), with one or more risk factors, such as prior stroke or transient ischaemic attack (TIA); age≥ 75 years; hypertension; diabetes mellitus; symptomatic heart failure (NYHA Class ≥ II).Treatment of deep vein thrombosis (DVT) and pulmonary embolism (PE), and prevention of recurrent DVT and PE in adults  for haemodynamically unstable PE patients.
Dossier Status: On-going 
Stability Studies: Zone II / Zone IVb
Shelf life (Originator): Three (3) years
Batch Size: To be defined
Pack Sizes: To be defined / Originator pack: BT x 14, 20, 28, 56, 60, 168 and 200 film-coated tablets

Read more Show less

ANFARM HELLAS S.A.

  • GR
  • 2015
    On CPHI since
View company profile
Categories
more categories Show less
Specifications
  • Supplied from
    Greece
More specifications Fewer specifications
Sales Markets
Show more Show less

ANFARM HELLAS S.A.

  • GR
  • 2015
    On CPHI since
View company profile

More Products from ANFARM HELLAS S.A. (4)

  • Amikacin Inj.Sol 500mg/2ml (EU CTD Available) & 1g/4ml (EU CTD Available: Q3 2021)

    Product Amikacin Inj.Sol 500mg/2ml (EU CTD Available) & 1g/4ml (EU CTD Available: Q3 2021)

    Amikacin Solution for Injection 
    Reference Product: Briklin® / BRISTOL-MYERS SQUIBB
    Description: Amikacin sulfate is indicated in the short-term treatment of serious infections due to susceptible strains of Gram-negative bacteria, including Pseudomonas species,&nb...
  • Azithromycin Pd.Sol.Inf 500mg/Vial (EU CTD Available)

    Product Azithromycin Pd.Sol.Inf 500mg/Vial (EU CTD Available)

    Azithromycin 500mg/Vial Powder for Solution for Infusion Reference Product: Zithromax® / PFIZER 
    Description: Azithromycin as powder for solution for infusion is indicated for the treatment of community-acquired pneumonia due to susceptible microorganisms in adult patients where initial intrav...
  • Brivaracetam Oral Solution 10mg/ml (EU CTD Available: Q4 2022)

    Product Brivaracetam Oral Solution 10mg/ml (EU CTD Available: Q4 2022)

    Brivaracetam 10mg/ml Oral Solution
    Reference Product: Briviact® / UCB
    Description: Brivaracetam is an antiepileptic agent which is indicated as adjunctive therapy in the treatment of partial onsetseizures with or without secondary generalization in adults, adolescents and children from 4 year...
  • Brivaracetam Sol. Inf 10mg/ml (5ml Vial) (EU CTD Available: Q3 2022)

    Product Brivaracetam Sol. Inf 10mg/ml (5ml Vial) (EU CTD Available: Q3 2022)

    Brivaracetam 10mg/ml (5ml Vial) Solution for Injection/Infusion
    Reference Product: Briviact® / UCB
    Description: Brivaracetam is an antiepileptic agent which is indicated as adjunctive therapy in the treatment of partial onsetseizures with or without secondary generalization in adults, adolescents and...

ANFARM HELLAS S.A. resources (2)